Introduction
============

Radicular pain induced by a lumbar herniated disc is an unbearable symptom for patients and has become a public health problem. More and more research have shown that the inflammatory and immune responses occurring in the peripheral[@b1-jpr-12-501]--[@b3-jpr-12-501] and central nervous systems[@b4-jpr-12-501] play a critical role in the progression of sciatica induced by lumbar disc herniation (LDH). Central sensitization in the spinal cord dorsal horn is closely involved in pain process in lumbar radiculopathy.[@b5-jpr-12-501],[@b6-jpr-12-501] Recent researches have been concentrated in the molecular targets in pain-signaling systems, such as G-protein-coupled receptors, ion channels in the glial, and neurons localized within the nociceptive pathways.[@b7-jpr-12-501] However, the molecular mechanism underlying radicular pain is largely unknown.

Recent studies found that lncRNAs play roles in regulation of gene expression via the control of cell cycle distribution, cell differentiation, and transcriptional and posttranscriptional regulation, and they are not simply some transcriptional byproducts.[@b8-jpr-12-501],[@b9-jpr-12-501] lncRNAs modulate gene transcription by affecting the binding ability of transcription factors and rearranging the chromatin.[@b10-jpr-12-501] lncRNAs also affect miRNA functions by controlling pre-mRNA splicing or acting as miRNA sponges.[@b11-jpr-12-501],[@b12-jpr-12-501] Evidence suggests that aberrant expression of lncRNAs occurs in various types of pain, including diabetic neuropathic pain, peripheral nerve injury pain caused by spinal nerve ligation and chronic constriction injury, cancer-associated pain, and osteoarthritis inflammation-related pain.[@b13-jpr-12-501]--[@b15-jpr-12-501] Although the expression signatures of many lncRNAs have been defined in the context of pain, expression levels to association and function based on expression levels of lncRNAs in LDH and pain-signaling pathways remain largely unknown

The spinal cord is a crucial area in processing of pain-related signals.[@b16-jpr-12-501],[@b17-jpr-12-501] Here, we analyzed the expression patterns of mRNAs and lncRNAs in the spinal dorsal horn between a group of rats treated with nucleus pulposus (NP) implantation and a sham group. We identified 103 mRNAs and more than 19 unique lncRNAs that were dramatically different in expression in rats with LDH by using micro-arrays. Some differentially expressed (DE) mRNAs and lncRNAs were further verified by quantitative PCR (qPCR) in six additional experiments. Then we used gene ontology (GO) and pathway analyses to analyze the biologic roles of these mRNAs and lncRNAs. Our study might provide a novel therapeutic target for the treatment of radicular pain in patients with LDH.

Materials and methods
=====================

Animals
-------

Experiments were performed on adult male Sprague-Dawley rats (body weight 220±20 g), which were approved by Soochow University. The total rats used in the present study were 68. These rats were housed under standard conditions (07:00--19:00 lighting, 24°C±2°C) with a unified laboratory diet and water. Experimental procedure of rats was performed according to the guidelines of the International Association for the Study of Pain. Because the paw withdraw threshold and WBD were at the maximum different point of the time-- response curve ([Figure 1A, C](#f1-jpr-12-501){ref-type="fig"}) and in order to minimize the suffering from pain of rats, almost all of the experiments were performed within 7 days after NP treatment.

Disc herniation model
---------------------

Surgeries for the LDH model were performed as previously described.[@b1-jpr-12-501] Briefly speaking, all experimental rats were deeply anesthetized with sodium pentobarbital (50 mg/kg body weight, intraperitoneally). The hair of the rat's lower back was shaved, and the skin was regularly disinfected by iodophor. NP was harvested from the coccygeal intervertebral disc level of each tail. Harvested NP (\~5 mg) was implanted next to the left L5 and L6 nerve roots just proximal to the corresponding DRG. Nonoperation was did on the right side of the dorsal root in all rats. The surgical procedure for the sham group was similar to the NP-treated group, but NP implantation was omitted.

Pain behavior test
------------------

Rats (n=8 for each group) were measured for mechanical pain sensitivity in plantar surface of the hindpaws at 3 days prior to surgery and 3, 7, 14, 21, 28, and 35 days after surgery in a double-blinded manner. Mechanical withdrawal thresholds (PWT) and thermal threshold were tested as previously described.[@b1-jpr-12-501],[@b3-jpr-12-501] In brief, mechanical withdrawal thresholds (PWT) were tested utilizing von Frey filaments (VFF). A series of calibrated VFF were applied to the plantar surface of the rat hind paw with sufficient force to bend the filaments for 10 seconds or until the rat withdrew. A filament of the next lower force was applied when a response occurred. The cutoff strength of VFF was set at 20.30 g to avoid the potential injury of the tissue. A 50% likelihood of stimulus production was determined by the "up-down" calculating assay. The average value of VFF force was determined as a withdrawal response. Each test was duplicated 3 times at a 2-minute interval.

Body weight-bearing test
------------------------

WBD test was performed by an incapacitance tester (PH-200, Taimeng Chengdu, China) as described previously.[@b1-jpr-12-501],[@b3-jpr-12-501] Results were determined as averages of three trials, with each trial measuring the hindlimb weight over 5 seconds. WBD is presented as weight on the contralateral limb minus weight on the ipsilateral limb. When one hindpaw has pain, the rat will not put more body weight to the leg. Therefore, the other leg will bear more body weight. The greater the body WBD is, the more pain the rat has. Thus, the weight-bearing asymmetry is indicative of hyperalgesia. All rats were tested 3 days before the operation and 3--35 after implantation of NP.

Rotarod test
------------

The rotarod system (ZH-300, Zhenghua, Anhui Province, China) for locomotor assessment was used to measure the time period for an animal to maintain its balance on a moving cylinder as previously described.[@b1-jpr-12-501] Thirty minutes after the conditioning, each animal was placed on the rotarod and its latency until falling was determined and expressed in seconds.

Tissue extraction and RNA isolation
-----------------------------------

Three rats from LDH treated and three from sham group were anesthetized with isoflurane and perfused through the ascending aorta with saline at 7 days after operation. The L5--L6 spinal cord segments were then extracted. Total RNAs were collected from the dorsal horn of spinal cord using Trizol reagent (Invitrogen, Carlsbad, CA, USA) based on the manufacturer's instructions. The RNA concentration and purity were examined using the NanoDrop 1000 Spectrophotometer (Thermo). Equal mRNA from one rat with the same treatment was mixed as one sample after these testing. Total of six samples (three from LDH and three from sham group) were selected for microarray analysis.

lncRNA and mRNA microarray expression profiling
-----------------------------------------------

The microarray profiling was tested in the research laboratory of the OE Biotechnology Company in Shanghai (China). The sample labeling, microarray hybridization, and washing were handled according to the manufacturer's standard protocols. In brief, mRNA was purified from total RNA by using an mRNA-only Eukaryotic mRNA Isolation Kit (Epicentre Biotechnologies, Madison, WI, USA). The RNA samples were hybridized to mouse lncRNA microarray. After washing, the arrays were scanned with the Agilent Scanner G2505C (Agilent Technologies). Array images and raw data were analyzed by using Extraction software (version 10.7.1.1, Agilent Technologies). Data were then normalized with the quantile algorithm. The probes with at least one condition out of two conditions flagged as "P" were chosen for further data analysis. Then, DE mRNAs and lncRNAs were identified with *P*-values and FC as calculated with *t*-test. The FC ≥1.5 and *P*-value \<0.05 were set for the up- and downregulated gene threshold. Hierarchical clustering was performed to determine the different mRNA and lncRNA expression patterns among these samples.

Bioinformatics analysis
-----------------------

Volcano plot filtering identified DE lncRNAs and mRNAs with statistical significance. The threshold used to screen RNAs with an FC \>1.5 was *P*\<0.05. Hierarchical clustering was carried out by Cluster 3.0, and the heat maps were generated in Java Treeview. The DE mRNAs that were adjacent to or overlapping with the DE lncRNAs were recognized as DE lncRNAs associated with mRNAs using the UCSC Genome Browser.

We first calculated coexpressed mRNAs for each DE lncRNA, and then we conducted a functional enrichment analysis of this set of coexpressed mRNAs. The enriched functional terms were used as the predicted functional terms of given lncRNA. The coexpressed mRNAs of lncRNAs were identified by calculating Pearson correlation with a correlation *P*-value \<0.05. We then used hypergeometric cumulative distribution function to calculate the enrichment of functional terms in annotation of coexpressed mRNAs. GO analysis and KEGG analysis were applied to determine the biologic roles of these DE mRNAs, based on the latest KEGG (database (<http://www.genome.jp/kegg/>). The *P*-value (hypergeometric *P*-value) denotes the significance of the pathway correlated to the conditions. The recommended *P*-value cutoff is 0.05.

RT-PCR
------

The microarray results were further confirmed by RT-PCR. The yield of RNA was determined using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA), and the integrity was evaluated using agarose gel electrophoresis stained with ethidium bromide. Quantification was performed with a two-step reaction process as described previously. The primer sequences were designed in the laboratory and synthesized by Generay Biotech (Generay, Shanghai, China) based on the mRNA sequences obtained from the NCBI database as follows: BMP4 (forward 5′-CCTGGTCAACTCC-GTTAATTC-3′; reverse 5′-TTCAACACCACCTTGTCG-3′), SLC17a8 (forward 5′-GCTGTGTCATGTGTGTGAG-3′/reverse 5′-AGAGGTTGTGGCTAGACGA-3′), Cacnals (forward 5′-CACCAATAAGATCCGCGTC-3′/reverse 5′-CTGATTCCTCATGGAGTCG-3′).

Statistical analysis
--------------------

Statistical analyses were carried out by using SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). All data are expressed as the mean ± SEM or proportions where needed. One-way ANOVA followed by Tukey's multiple comparison tests, paired *t*-test, or unpaired *t*-test was used for comparisons. GraphPad Prism 5.0 (GraphPad Software, San Diego, CA, USA) was used to manage all graphs. *P*-values \<0.05 (two-tailed) were considered statistically significant.

Results
=======

Pain hypersensitivity induced by transplantation of autologous NP
-----------------------------------------------------------------

Autologous NP was harvested from the tails of rats and implanted in the lumbar 5 and lumbar 6 spinal nerve roots, which caused pain hypersensitivity in the rats when compared with the sham group. In the LDH group, the mechanical paw withdrawal threshold (PWT) markedly reduced at 3 days after surgery, which indicated mechanical pain allodynia. The change returned to the normal level on day 35 after implantation (\**P*\<0.05, [Figure 1A](#f1-jpr-12-501){ref-type="fig"}). The NP-treated rats exhibited a remarkable decrease in the thermal paw withdrawal latency (PWL) compared to the sham group. The PWL was decreased at 7 days after NP treatment and returned to the baseline level at day 14 ([Figure 1B](#f1-jpr-12-501){ref-type="fig"}, n=6 for each group, \**P*\<0.05). Compared to the sham group, the LDH group also demonstrated a dramatic increase in body weight-bearing difference (WBD). The WBD was increased on day 3 after the NP implantation and returned to the baseline level on day 35 ([Figure 1C](#f1-jpr-12-501){ref-type="fig"}, \**P*\<0.05). We performed rotarod tests to determine whether the motor performance was affected by the surgery. There was no significant difference in the time to fall on the rotarod at a speed of 20 rpm ([Figure 1D, *P*](#f1-jpr-12-501){ref-type="fig"}\>0.05).

mRNAs and lncRNAs expression profiles in LDH
--------------------------------------------

We next examined the expression profiles of the mRNAs and lncRNAs in the L5--L6 spinal cord at 7 days after LDH or sham by microarray. From the hierarchical clustering and scatter plot analysis results, we obtained an overview of the expression signatures of the mRNAs and lncRNAs. The scatter plots demonstrated that large numbers of the lncRNAs and mRNAs were DE between the LDH and the sham group ([Figure 2A, B](#f2-jpr-12-501){ref-type="fig"}). Hierarchical cluster analysis of the lncRNAs and mRNAs demonstrated that the three LDH or three sham samples were clustered together, and the signal intensity was consistent in the LDH and sham groups ([Figure 2C, D](#f2-jpr-12-501){ref-type="fig"}). The heatmap of the DE lncRNAs or mRNAs that were upregulated or downregulated by 1.5-fold was magnified ([Figure 2E, F](#f2-jpr-12-501){ref-type="fig"}), which indicated concordance in the LDH and sham groups. These differential alterations in the mRNAs and lncRNAs in the spinal cord are correlated with radicular pain.

DE lncRNAs and mRNAs
--------------------

To further analyze the DE lncRNAs, we used the significance analysis of microarrays method, following the criteria *P*-value \<0.05 and fold change (FC) \>1.5. The results revealed that 19 lncRNAs, which comprised 13 upregulated and 6 downregulated lncRNAs, were greatly altered in the LDH group compared to the sham group. The most enhanced lncRNAs were TCONS_00043124, TCONS_00036317, T C O N S \_ 0 0 0 1 4 2 3 8, T C O N S \_ 0 0 0 8 9 3 7 5 , TCONS_00031848, and TCONS_00095748. The most reduced lncRNAs were TCONS_00040686, XR_086254.1, TCONS_00122314, TCONS_00135380, TCONS_00121583, and TCONS_00036854. Of the significantly altered lncRNAs, TCONS_00043124 was the most upregulated, with an FC of 2.661, whereas TCONS_00040686 was the most downregulated, with an FC of 1.777. The detailed information of the DE lncRNAs is shown in [Table 1](#t1-jpr-12-501){ref-type="table"}.

In the DE mRNAs, there were 103 genes that exhibited greater than a 1.5-FC. The number of downregulated mRNAs (63) was greater than the number of upregulated mRNAs (40) in LDH. These DE mRNAs corresponded to many known genes involved in pain processing, including Cxcl13, Slc17a8,[@b18-jpr-12-501] Ccr5,[@b19-jpr-12-501] Cacna1s, P2ry2, and Tnnc2.[@b20-jpr-12-501] Detailed information regarding the top 20 upregulated and 20 downregulated mRNAs is shown in [Table 2](#t2-jpr-12-501){ref-type="table"}.

Real-time qPCR confirmation of mRNA and lncRNA expression
---------------------------------------------------------

To confirm the reliability of the microarray data and analyze the temporal alterations in mRNA and lncRNA expression after LDH, the lncRNAs TCONS_00031848 and TCONS_00122118 and the mRNAs BMP4, SLC17a8, and Cacnals were randomly selected and analyzed by qPCR. The spinal cord tissues were collected from the sham and LDH rats before operation and 3, 7, 14, 21, 28, and 35 days post operation. BMP4 (bone morphogenetic protein 4), a protein-coding gene associated with the TGF-beta-signaling pathway, was significantly decreased at 7 days and persisted until 14 days post operation ([Figure 3A](#f3-jpr-12-501){ref-type="fig"}). SLC17a8 (solute carrier family 17 member 8, also known as Vglut3) exhibits glutamate transporter activity and may play a role in glutamate transport in the synaptic vesicles of cholinergic and serotoninergic neurons. SLC17A8 was significantly increased at 7 days and until 14 days post operation ([Figure 3B](#f3-jpr-12-501){ref-type="fig"}). The lncRNAs TCONS_00031848 and TCONS_00122118 were both significantly increased at 7 and 14 days post operation ([Figure 3C, D](#f3-jpr-12-501){ref-type="fig"}). In addition, the FCs of these lncRNAs and mRNAs detected by qPCR in the LDH tissue at 7 days post operation were consistent with the results from the microarray ([Figure 3E](#f3-jpr-12-501){ref-type="fig"}), which further supported the reliability of the array data.

Functional prediction of DE mRNAs and lncRNA in LDH
---------------------------------------------------

To investigate the molecular mechanisms in radicular pain, we conducted GO and pathway analysis of the DE genes in LDH vs sham. The GO results demonstrated that the most significantly enriched biologic processes of the upregulated genes in LDH were chemotaxis, immune response, and inflammatory responses ([Figure 4A](#f4-jpr-12-501){ref-type="fig"}). The most significantly enriched cellular components of the upregulated genes in LDH were extracellular space, apical dendrite, and extrinsic component of plasma membrane ([Figure 4B](#f4-jpr-12-501){ref-type="fig"}). The most significantly enriched molecular functions of the upregulated genes in LDH were chemokine activity and CXCR chemokine receptor activity ([Figure 4C](#f4-jpr-12-501){ref-type="fig"}). The most significantly enriched biologic processes of the downregulated genes in LDH were negative regulation of phosphorylation, membrane depolarization during action potential, positive regulation of the BMP-signaling pathway, and negative regulation of mitogen-activated protein kinase activity ([Figure 4D](#f4-jpr-12-501){ref-type="fig"}). The most significantly enriched cellular components of the downregulated genes in LDH were the extracellular region, the anchored component of the membrane, and the nucleolar ribonuclease P complex ([Figure 4E](#f4-jpr-12-501){ref-type="fig"}). The most significantly enriched molecular functions of the downregulated genes in LDH were co-receptor binding, IL-17 receptor activity, glycerophosphodiester phosphodiesterase activity, and calcium-dependent phospholipase A2 activity ([Figure 4F](#f4-jpr-12-501){ref-type="fig"}).

Similarly, we analyzed the DE genes in Kyoto Encyclopedia of Genes and Genomes (KEGG). The results demonstrated that the upregulated genes in LDH were involved in the chemokine-signaling pathway, *Staphylococcus aureus* infection, cytokine-- cytokine receptor interaction, glycosphingolipid biosynthesis, the toll-like receptor-signaling pathway, and the NF-kappa B-signaling pathway ([Figure 5A](#f5-jpr-12-501){ref-type="fig"}). The downregulated genes in LDH were involved in ether lipid metabolism, basal cell carcinoma, Hippo-signaling pathway, neuroactive ligand--receptor interaction, and calcium-signaling pathway ([Figure 5B](#f5-jpr-12-501){ref-type="fig"}).

Function prediction of mRNAs and lncRNAs
----------------------------------------

As some lncRNAs have been reported to play critical roles in regulation of the expression of their neighboring genes, we conducted additional screening for DE lncRNAs associated with mRNAs. Briefly, we identified and performed a functional enrichment analysis of the coexpressed mRNAs for each different lncRNA. The coexpressed mRNAs of the lncRNAs were identified by calculating the Pearson correlation with a correlation *P*-value \<0.05. We performed the GO and pathway analysis with the top 200 DE mRNAs and lncRNAs to investigate the potential biologic relationships. GO and pathway analyses suggested that some functional pathways were identified. Among these pathways, voltage-gated potassium channel activity, BMP receptor binding, sensitive calcium-release channel activity, and RNA polymerase II regulatory region sequence-specific DNA binding were the most closely associated with LDH ([Figure 6A](#f6-jpr-12-501){ref-type="fig"}). Additionally, a KEGG pathway analysis demonstrated associations with some pathways, including sphingolipid metabolism, cell cycle, oxytocin-signaling pathway, glutamatergic synapse, and Hippo-signaling pathway ([Figure 6B](#f6-jpr-12-501){ref-type="fig"}).

Discussion
==========

LDH caused radicular pain that affects the nervous system.[@b21-jpr-12-501],[@b22-jpr-12-501] Evidence has indicated that gene expression plays important roles in the initiation and development of neuropathic pain.[@b23-jpr-12-501],[@b24-jpr-12-501] In recent years, the underlying molecular mechanisms of radicular pain have been widely studied; however, the epigenetic process of pain is still unclear.[@b25-jpr-12-501] lncRNAs have complicated molecular functions, including regulating protein activities, serving structural or organizational roles, serving as precursors to small RNAs, modulating transcriptional patterns, and altering RNA-processing events.[@b26-jpr-12-501] The function of lncRNAs in regulating the gene expression of neuropathic pain is unclear. In this study, we identified the DE lncRNAs in the spinal cord under a radicular pain condition and analyzed their characteristics and possible relationships with mRNAs.[@b27-jpr-12-501] A total of 9,984 lncRNAs were found in the spinal cord of the LDH rats. Among these lncRNAs, 13 lncRNAs were upregulated, and 6 lncRNAs were downregulated at 7 days after the NP treatment. Additionally, qRT-PCR was used to confirm the microarray analysis results, and findings were consistent with the microarrays data of spinal cords from the LDH and sham groups, which suggested that lncRNAs might be involved in radicular pain processing. These findings might provide novel insights into the molecular mechanism of neuropathic pain.

Among the DE mRNAs, the number of upregulated mRNAs did not exceed the number of downregulated mRNAs in the LDH spinal cords, which reveals the new pathways and biologic processes in neuropathic pain. Many pain-related genes, including Cacna1s, Cxcl13, Cxcl12, Ccr5, Mki67, Asb15, and Tnnc2, were significantly enhanced after LDH. In addition, many other mRNAs, such as BMP4, Nkd1, Fzd6, Slc17a8, and Gpr35, with unclear functions in the spinal cord (especially in neuropathic pain), were also screened out. As the DE genes may be related to nerve damage and glial cell activation to immune and inflammatory responses, further investigations are needed to confirm whether they are involved in pain hypersensitivity.

According to the GO and KEGG enrichment analyses of the DE mRNAs, we showed that the significantly enriched biologic processes and molecular functions of the upregulated genes in LDH vs sham were mainly involved in the chemokine signaling pathway,[@b28-jpr-12-501],[@b29-jpr-12-501] inflammation,[@b30-jpr-12-501] and immune response.[@b31-jpr-12-501] These findings are consistent with previous studies showing that neuroinflammation[@b32-jpr-12-501] and the inflammatory mediators produced in the peripheral and central nervous system (CNS) play a very important role in hyperalgesia.[@b33-jpr-12-501],[@b34-jpr-12-501] From the significant pathway analyses of the DE genes, we showed some significantly enriched pathways of the upregulated genes in LDH vs sham, such as the cytokine--cytokine receptor interaction, the toll-like receptor-signaling pathway, and the NF-kappa B-signaling pathway. Indeed, Tlr4 and NF-kappa B have been indicated as potential mechanisms in neuropathic pain and other pain models.[@b35-jpr-12-501] Collectively, the results suggest that anti-inflammation may be an effective therapeutic target for radicular pain.

Although lncRNAs play key roles in the regulation of gene expression, the major functional principles and regulatory mechanisms of lncRNAs are complex and obscure. Unlike miRNAs, there are no common approaches that can be used to predict the target genes and functions of lncRNAs by their sequence information or secondary structure. A large number of studies suggest that a number of lncRNAs can activate or repress the expression of their neighboring or overlapping genes.[@b8-jpr-12-501] Our further analysis showed that an upregulated lncRNA, TCONS_00089375, regulates the expression of a neighboring gene, Cstf3, through a cis transcriptional mechanism, and the downregulated lncRNA, TCONS_00036854, regulates a neighboring gene, Ppp1r15b, through a cis transcriptional mechanism in the LDH model. In the spinal cord after LDH, TCONS_00031848 was found to be associated with the Hippo-signaling pathway and influenced BMP4, Bmp2, Fzd3, Ndk1, Wnt16, and Wnt8a signaling. Of note is that our present study showed that autologous NP application to the spinal nerve produced persistent mechanical pain hypersensitivity. However, the thermal hypersensitivity is not remarkable. It is transient and not as prominent as the mechanical data. The mechanisms remain unknown. Future investigation of roles of DE genes in mechanical and thermal hypersensitivity is definitely helpful.

In summary, our results demonstrated that lncRNA transcripts were DE in the spinal cord after LDH. A total of 19 DE lncRNAs were shown to have neighboring or overlapping mRNAs in the genome. These lncRNAs may regulate the expression of their associated proteins and genes and play important roles in the pathogenesis of radicular pain. Future study of the lncRNAs found in our investigations will likely focus on their functions and their relationship with LDH. Nevertheless, our study might provide important information for exploring potential targets for the treatment of neuropathic pain.
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![LDH induces persistent neuropathic pain of rat hindpaw.\
**Notes:** NP treatment produced persistent mechanical allodynia (**A**) and heat hyperalgesia (**B**). In rats treated with NP, the body weight-bearing difference was dramatically increased between hindlimbs at 3, 7, 14, 21, and 28 days after surgery compared to the sham group (**C**). NP-treated rats did not produce any effect on the time to fall for LDH rats in the rotarod test (**D**). Data are expressed as mean ± SEM (n=6 for each group). \**P*\<0.05, two-way repeated-measures ANOVA.\
**Abbreviations:** LDH, lumbar disc herniation; NP, nucleus pulposus; PWT, paw withdrawal threshold; WB, weight borne.](jpr-12-501Fig1){#f1-jpr-12-501}

![LDH results in the expression profiling changes of mRNA and lncRNA in spinal cord dorsal horn.\
**Notes:** Scatter plot comparing global mRNA (**A**) or lncRNA (**B**) gene expression profiles in the spinal cord between the LDH and sham groups. Green lines indicate 1.5-fold differences in either direction in mRNA and lncRNA expression. Heat map showing hierarchical clustering of overall lncRNAs (**C**) or mRNA (**D**) expression pattern of reliably measured probe sets. Heat map showing hierarchical clustering of lncRNAs (**E**) or mRNA (**F**), whose expression changes were more than 1.5-fold. In clustering analysis, upregulated and downregulated genes were colored in red and green, respectively.\
**Abbreviation:** LDH, lumbar disc herniation.](jpr-12-501Fig2){#f2-jpr-12-501}

![Real-time quantitative PCR validations of two mRNAs and two lncRNAs in the spinal cord from NP-treated rats.\
**Notes:** The expressions of mRNA BMP4 were significantly downregulated at 7 and 14 days after LDH (**A**), mRNA SLC17a8 (**B**), lncRNA TCONS_00031848 (**C**), and lncRNA TCONS_00122118 (**D**) were significantly upregulated at 7 and 14 days after LDH. The fold changes of these lncRNAs and mRNAs at 7 days after NP treatment were consistent with the results from the microarray (**E**). One-way ANOVA followed by Tukey's multiple-comparison test. \**P*\<0.05.\
**Abbreviations:** BMP, bone morphogenetic protein; LDH, lumbar disc herniation; NP, nucleus pulposus.](jpr-12-501Fig3){#f3-jpr-12-501}

![Biologic functions of differentially expressed mRNAs.\
**Notes:** The significant biologic process, cellular component, and molecular function of upregulated mRNAs (**A--C**). The significant biologic process, cellular component, and molecular function of downregulated mRNAs (**D--F**).\
**Abbreviations:** BMP, bone morphogenetic protein; MAP, mitogen-activated protein.](jpr-12-501Fig4){#f4-jpr-12-501}

![Pathway analysis for differentially expressed mRNAs with fold changes \>1.5.\
**Notes:** The significant pathways for upregulated genes in NP-treated group (**A**). The significant pathways for downregulated genes in NP-treated group (**B**).\
**Abbreviations:** KEGG, Kyoto Encyclopedia of Genes and Genomes; NP, nucleus pulposus.](jpr-12-501Fig5){#f5-jpr-12-501}

![Function prediction of lncRNAs and mRNAs.\
**Notes:** Molecular function enrichment analysis of differentially expressed lncRNA-related mRNAs. Gene ontology analysis indicated that several functional pathways were enriched (**A**). KEGG pathway analysis showed associations with some pathways (**B**).\
**Abbreviations:** BMP, bone morphogenetic protein; KEGG, Kyoto Encyclopedia of Genes and Genomes; PPAR, peroxisome proliferator-activated receptor.](jpr-12-501Fig6){#f6-jpr-12-501}

###### 

The details of the differentially expressed lncRNAs

  Source lD                   *P*-value   FC (abs)   Regulation
  --------------------------- ----------- ---------- ------------
  **Upregulated lncRNAs**                            
  TCONS 00043124              0.043       2.661      Up
  TCONS 00036317              0.029       1.768      Up
  TCONS 00014238              0.006       1.752      Up
  TCONS 00089375              3.31E--04   1.709      Up
  TCONS 00031848              0.003       1.645      Up
  TCONS 00095748              0.009       1.635      Up
  TCONS 00122118              0.002       2.602      Up
  TCONS 00050883              8.14E--04   1.544      Up
  TCONS 00106609              0.033       1.541      Up
  TCONS 00113822              0.031       1.541      Up
  TCONS 00121610              0.034       1.536      Up
  TCONS 00091440              0.014       1.530      Up
  uc.253+                     0.009       1.504      Up
  **Downregulated lncRNAs**                          
  TCONS 00040686              0.010       1.777      Down
  XR 086254_1                 0.032       1.664      Down
  TCONS 00122314              0.036       1.655      Down
  TCONS 00135380              0.050       1.593      Down
  TCONS 00121583              0.005       1.549      Down
  TCONS 00036854              0.049       1.548      Down

**Abbreviation:** FC, fold change.

###### 

The details of the top 20 upregulated and 20 downregulated mRNAs

  Probe name                Gene symbol    FC (abs)   *P*-value   Regulation   Description
  ------------------------- -------------- ---------- ----------- ------------ ---------------------------------------------------------------------
  **Upregulated genes**                                                        
  A_64_P013437              *Cxcl13*       11.130     0.012       Up           C-X-C motif chemokine ligand 13
  A_64_P050430              *LOC679608*    5.000      0.010       Up           Hypothetical protein LOC679608
  A_64_P052265              *Klral*        3.548      0.031       Up           Killer cell lectin-like receptor, subfamily A, member 1
  A_64_P013753              *LOC68 5411*   3.228      0.048       Up           Similar to spermatogenesis-associated glutamate (E)-rich protein 4b
  A_64_P019790              *CYP2d1*       2.812      0.036       Up           Cytochrome P450, family 2, subfamily d, polypeptide 1
  A_44_P102353S             *C3*           2.709      0.048       Up           Complement component 3
  A_64_P150326              *LOC688649*    2.364      0.040       Up           Similar to spermatogenesis-associated glutamate (E)-rich protein 4d
  A_64_P140936              *Zfp39*        2.219      0.402       Up           Zinc finger protein 39
  A_64_P083999              *RGD1564933*   2.268      0.026       Up           Similar to olfactory receptor O1r271
  A_44_P807861              *Six4*         1.926      0.012       Up           SIX homeobox 4
  A_64_P107991              *Gpr31*        1182       0.040       Up           G-protein-coupled receptor 31
  A_64_P004S54              *Ptafr*        1.834      0.029       Up           Platelet-activating factor receptor
  A_64_P012557              *Fam64a*       1.808      0.022       Up           Family with sequence similarity 64, member A
  A_44_P294914              *Sec1*         1.214      0.009       Up           Secretory blood group 1
  A_44_P34S999              *Asb15*        1.511      0.045       Up           Ankyrin repeat and SOCS box containing 15
  A_64_P135843              *Grb7*         1.708      0.041       Up           Growth factor receptor bound protein 7
  A_PO_47636                *S1c17a8*      1.619      0.011       Up           Solute carrier family 17 member 8
  A_42_P797117              *RGD1311429*   1.667      0.025       Up           KAT8 regulatory NSL complex subunit 1
  A_44_P113974              *CCr5*         1.666      0.044       Up           Chemokine (C-C motif) receptor 5
  A_64_P021440              *Slc10a6*      1.645      0.041       Up           Solute carrier family 10 member 6
  **Downregulated genes**                                                      
  A_44_P236197                             6gi42      0.011       Down         IL-induced protein with tetratricopeptide repeats 1
  A_64_P057196              *Cldn14*       4.658      0.022       Down         Claudin 14
  A_64_P011679              *Caznals*      2.995      0.035       Down         Calcium voltage-gated channel subunit alpha l S
  A_64_P029118              *Loxl4*        2.368      0.039       Down         Lysyl oxidase-like 4
  A_44_P314087              *LOC681186*    2.346      0.011       Down         Hypothetical protein LOC681186
  A_44_P520159              *P2ry2*        2.312      0.001       Down         Purinergic receptor P2Y2
  A_64_P158g22              *Ptgdrl*       2.309      0.021       Down         Prostaglandin D2 receptor-like
  A_64_P115212              *I117rb*       2.183      0.015       Down         IL 17 receptor B
  A_64_P003051              *01r5*         2.159      0.023       Down         Olfactory receptor 5
  A_64_P0930SS              *01r1206*      2.151      0.011       Down         Olfactory receptor 1206
  A_64_P074305              *01r440*       2.144      0.007       Down         Olfactory receptor 440
  A_43_P16403               *Clca1*        2.032      3.50E--04   Down         Chloride channel accessory 1
  A_44_P374618              *Cdknlc*       1.915      0.031       Down         Cyclin-dependent kinase inhibitor 1C
  A_64_P1650S5              *Cdknlc*       1.955      0.018       Down         Cyclin-dependent kinase inhibitor 1C
  A_64_P029486              *Tnnc2*        1.940      0.045       Down         Troponin C type 2
  A_44_P325599              *Vwa7*         1.132      0.003       Down         von Willebrand factor A domain containing 7
  A_64_P096782              *Ier5l*        1.397      0.030       Down         Immediate early response 5-like
  A_44_P231955              *Reml*         1.271      6.09E--04   Down         RRAD and GEM like GTPase 1
  A_43_P11922               *Crem*         1.746      0.035       Down         cAMP-responsive element modulator
  A_44_P401146              *Npm2*         1.133      0.015       Down         Nucleophosmin/nucleoplasmin 2

[^1]: These authors contributed equally to this work
